
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Citrullus colocynthis fruit extracts reduce inflammatory cytokines IL-6 and TNF-α while inhibiting CXCL-1/KC chemokine expression and glucosidase activity. The plant demonstrates dose-dependent anti-inflammatory effects through neutrophil infiltration reduction in colitis models.

Reported Benefits (Provisional)
Origin & History

Citrullus colocynthis, commonly known as Bitter Apple, is native to the desert margins, arid plains, and sandy soils of North Africa, the Middle East, and parts of South Asia. This resilient fruit is historically valued in traditional medicine for its potent purgative and detoxifying properties.
Research Narrative (Provisional)
Scientific literature supports Bitter Apple's traditional uses, highlighting its purgative, anti-inflammatory, and antimicrobial properties. Studies have explored its potential in liver detoxification and metabolic regulation, though further clinical research is warranted for human applications.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Dietary Fiber: Supports gut microbiome health, digestion, and glycemic control. - Minerals: Potassium, Magnesium, Calcium (aid muscle function, hydration, enzymatic activity). - Phytochemicals: Cucurbitacins (notably cucurbitacin E) (potent purgative, anti-inflammatory, antimicrobial activity). - Phytochemicals: Flavonoids, Saponins, Glycosides, Tannins, Alkaloids (anti-inflammatory, detoxifying, antimicrobial, laxative properties). - Plant Sterols: Assist cholesterol metabolism and cardiovascular wellness.
Reported Mechanism (Provisional)
Bitter apple extracts (aqueous, ethanolic, ethyl acetate) reduce neutrophil infiltration and suppress CXCL-1/KC chemokine expression in inflammatory conditions. The fruit inhibits glucosidase enzyme activity, contributing to antihyperglycemic effects, while demonstrating dose-dependent reductions in pro-inflammatory cytokines IL-6 and TNF-α in carrageenan-induced inflammation models.
Clinical Narrative (Provisional)
A pilot double-blind RCT with 34 cancer patients applied topical C. colocynthis oil twice daily for 2 months to treat chemotherapy-induced peripheral neuropathy. No significant improvement occurred in FACT/GOG-Ntx total scores (2.40 ± 1.90 drug vs. 1.05 ± 1.36 placebo, p = 0.879). Scientific literature supports traditional anti-inflammatory and antimicrobial uses in preclinical studies, but robust human clinical evidence remains limited.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







